The revenue from antiretroviral drug formulations of Aurobindo Pharma Limited in fiscal year 2023 was over nine billion Indian rupees. This value was a significant increase from the previous financial year 2022.
Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2023
(in billion Indian rupees)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Aurobindo Pharma. (August 1, 2023). Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2023 (in billion Indian rupees) [Graph]. In Statista. Retrieved October 06, 2024, from https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/
Aurobindo Pharma. "Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2023 (in billion Indian rupees)." Chart. August 1, 2023. Statista. Accessed October 06, 2024. https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/
Aurobindo Pharma. (2023). Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2023 (in billion Indian rupees). Statista. Statista Inc.. Accessed: October 06, 2024. https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/
Aurobindo Pharma. "Revenue from Antiretroviral Drug Formulations by Aurobindo Pharma Limited from Financial Year 2013 to 2023 (in Billion Indian Rupees)." Statista, Statista Inc., 1 Aug 2023, https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/
Aurobindo Pharma, Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2023 (in billion Indian rupees) Statista, https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/ (last visited October 06, 2024)
Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2023 (in billion Indian rupees) [Graph], Aurobindo Pharma, August 1, 2023. [Online]. Available: https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/